CD274 and neoplasm: Research has illustrated that PD-L1 upregulation in tumor cells, particularly when combined with PD-1 produced by tumor-infiltrating activated T cells, may cause exhaustion and suppress the antitumor immunological function of these effector cells, which allows tumor cells to escape the immune system [46].